Qiaoling Pan

机构：Ningbo Medical Center Lihuili Hospital, National Center for Infectious Diseases · ORCID：0000-0002-3771-8193

发表论文 79 篇 · 总被引 1923 次 · h-index 26

代表论文

• ROS-responsive polymer nanoparticles with enhanced loading of dexamethasone effectively modulate the lung injury microenvironment (2022 · Acta Biomaterialia · 被引 128)
• Organoids: development and applications in disease models, drug discovery, precision medicine, and regenerative medicine (2024 · MedComm · 被引 77)
• Mesenchymal stem cells alleviate mouse liver fibrosis by inhibiting pathogenic function of intrahepatic B cells (2024 · Hepatology · 被引 56)
• MSCs alleviate LPS-induced acute lung injury by inhibiting the proinflammatory function of macrophages in mouse lung organoid–macrophage model (2024 · Cellular and Molecular Life Sciences · 被引 45)
• Isoliquiritigenin inhibits gastric cancer growth through suppressing GLUT4 mediated glucose uptake and inducing PDHK1/PGC-1α mediated energy metabolic collapse (2023 · Phytomedicine · 被引 42)
• MSC-derived exosomes attenuate hepatic fibrosis in primary sclerosing cholangitis through inhibition of Th17 differentiation (2024 · Asian Journal of Pharmaceutical Sciences · 被引 36)